by Sara M. Nolte | Jan 15, 2018
With the start of a new year, I like to take a moment to think about what things in cancer research got me really excited the previous year. Beyond a doubt, that thing for me in 2017 was the first (and second!) FDA approval of a CAR T-cell (chimeric antigen receptor...
by Sowmya Viswanathan | Jan 8, 2018
In this month’s blog on addressing specific bioprocess and bioanalytical challenges to develop Cell and Gene Therapies (CGTs), we hear from Dr. Nick Timmins on quantifying performance of CGTs using cell yield, and some of the methods to measure it, as a metric...
by Stacey Johnson | Dec 22, 2017
This time of year is special for many reasons, and traditions are a big part of that. It’s risky to mess with traditions; many people look forward to, and value, the familiarity and ritual of repeating something they have done for years, or even decades. You might...
by Stacey Johnson | Dec 15, 2017
If I say the names Kirsty Duncan, Mona Nemer, Julie Payette and Molly Shoichet, what comes to mind? There are many ways to answer that question, of course, but the answer I’m looking for is that they are all female scientists or engineers who hold significant...
by Laine Bodnar | Dec 8, 2017
The holidays are right around the corner. If you have a child or pre-teen in your life, the pressure is on to find that perfect gift. Since you’re reading Signals, you probably understand the value of encouraging kids to be enthusiastic about science, technology,...
by Nicole Kuchinsky | Dec 5, 2017
One of my personal highlights from this year’s Till and McCulloch Meetings was attending the “Science for Citizens” panel (reported on in a previous post). Experts including Timothy Caulfield, patient advocate William Brock, and National Post writer Tom...
by Stacey Johnson | Dec 1, 2017
Eleven months in to 2017, I’m confident you’ve heard of Canada 150: a government-led initiative to celebrate and recognize Canada’s “150th” year – that number is widely disputed by the way. If Canada 150 does not sound familiar, you can find information and...
by Sowmya Viswanathan | Nov 30, 2017
The recent FDA approvals of Kymriah™ for the treatment of children and young adults with B-cell Acute Lymphoblastic Leukemia, and Yescarta™ to treat adults with certain types of non-Hodgkin lymphoma, and the unanimous endorsement by an FDA advisory committee of a gene...
by Stacey Johnson | Nov 24, 2017
Happy Thanksgiving to our American family, friends and colleagues. It may feel like 2017 didn’t offer quite as much to be thankful for on a global level, but there was one uplifting international event that rocked our world. Despacito. On January 12, 2017, Universal...
Comments